FLT3-Selective PROTAC: Enhanced Safety and Increased Synergy with Venetoclax in FLT3-ITD Mutated Acute Myeloid Leukemia.
Tan Y, Xin L, Wang Q, Xu R, Tong X, Chen G, Ma L, Yang F, Jiang H, Zhang N, Wu J, Li X, Guo X, Wang C, Zhou H, Zhou F.
Tan Y, et al. Among authors: yang f.
Cancer Lett. 2024 May 3:216933. doi: 10.1016/j.canlet.2024.216933. Online ahead of print.
Cancer Lett. 2024.
PMID: 38705564